As shares of Boston-based Vertex shot higher on the news of its non-opioid pill, Journavx, we took a look at investment in ...

Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ Suzetrigine, sold as twice-daily Journavx, a non-addictive prescription drug for ...

Federal officials have approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin. The U.S.

DUSHANBE, Tajikistan, February 5. Vertex, a Russian pharmaceutical manufacturer, is engaging in discussions with companies in ...

From packable sleeping pads to ultracomfortable air beds, we tested and found the best camping mattresses and sleeping pads ...

Thank you for standing by for the Alphabet fourth quarter and fiscal year 2024 earnings conference call. At this time, all ...

Maia, as the AI bot is called, is the first of its kind in Singapore and takes only a 0.2% commission. Read more at straitstimes.com.

Get ready for a cool, jazzy, spell-binding February. Musicians from New York and the Midwest are bringing innovative concerts ...

The bottom line: We raise our fair value estimate for wide-moat Alphabet to $237 per share from $220 as we bake in the firm’s ...

If you've played a game using Unreal Engine, or for that matter any modern game engine, you've likely encountered various forms of stuttering. One major issue is shader stuttering, as games build up ...